Aggeris-C
K-Number: K220182 · 2022-03-30
ApplicantClariance
Decision Date2022-03-30
Product CodeKWQ
Advisory CommitteeOR
DecisionSubstantially Equivalent
Device Summary
Aggeris-C is a medical device manufactured by Clariance. It received FDA 510(k) clearance on 2022-03-30 under approval number K220182. The device is classified under product code KWQ. It was reviewed by the OR advisory panel. FDA Decision: Substantially Equivalent.
Frequently Asked Questions
What is the Aggeris-C?
Aggeris-C is a medical device that received FDA 510(k) clearance on 2022-03-30. It is manufactured by Clariance. The 510(k) number is K220182.
When was Aggeris-C approved by the FDA?
Aggeris-C received FDA 510(k) clearance on 2022-03-30, under approval number K220182.
What company makes Aggeris-C?
Aggeris-C is manufactured by Clariance.
What is the FDA product code for Aggeris-C?
The FDA product code for Aggeris-C is KWQ.
Other Devices by Clariance
Related Devices (Code: KWQ)
K160982SphynxEden Spine, LLC
K162638CETRA Anterior Cervical Plate SystemOrthofix, Inc.
K162194MEDICREA INTERNATIONAL Anterior Cervical Locking Plate SystemMedicrea International SA
K162211AccuFit Lateral Plate SystemPrecision Spine, Inc.
K162250FortiBridge Anterior Cervical Plate SystemNanovis Spine, LLC
K162664Pyrenees Cervical Plate SystemK2m, Inc.
Official Source
View on FDA Database →Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.